Dr Gerald Goh has 10+ years of research experience in using genetics to understand the biology and underlying mechanisms of various human diseases, from autism to cancer. His career in oncology research began with the use of exome sequencing for the identification of driver genes in a variety of human cancers, using some of the first whole-exome capture arrays to interrogate the mutational landscape in these cancers. His work with numerous key opinion leaders around the world has resulted in over 25 peer-reviewed publications in high-impact journals including Nature Genetics. Prior to joining Illumina, Gerald was part of the business development team at the Genome Institute of Singapore, stimulating research collaborations and industry partnerships in oncology. His current focus is on driving momentum in next-generation sequencing applications across the cancer continuum. Gerald received his PhD in Genetics from Yale University and holds a Bachelors from the University of Chicago.